Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H.E.L Group develops and manufactures innovative scientific instruments and automation software to optimize efficiency, safety, and productivity in chemistry and biology labs. Their products support R&D in pharmaceuticals, biotechnology, chemicals, batteries/energy storage sectors. The company has over three decades of experience providing custom solutions for process development—from research to pilot scale—including automated reactors/bioreactors and calorimetry equipment. They do not develop therapeutics or diagnostics themselves but enable life science innovation through their technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H.E.L Group.